跳至主要内容
临床试验/ISRCTN15674970
ISRCTN15674970已完成未知

Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (the TLC study)

niversity of Birmingham0 个研究点目标入组 3,040 人开始时间: 2021年11月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
3,040

研究概览

简要总结

2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/35879616/ Symptoms and risk factors for long COVID (added 01/08/2022) 2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35473737/ (added 01/08/2022)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Non-hospitalised individuals aged 18 years and older with a positive RT-PCR test for SARS-CoV-2 in CPRD Aurum (minimum 2000 participants)
  • Propensity score-matched individuals without a diagnosis of COVID-19 (suspected or confirmed) in CPRD Aurum and without a positive SARS CoV-2 RT-PCR result and without a record of hospital admission within 28 days of the index date (minimum 500 participants)

排除标准

  • Aged under 18 years or hospitalised for COVID-19:
  • 1. Individuals without a positive SARS CoV-2 RT-PCR test result in CPRD Aurum
  • 2. Individuals with a hospital admission within 28 days of a positive SARS CoV-2 RT-PCR result in CPRD Aurum
  • 3. Individuals aged under 18 years
  • 4. Individuals unable/unwilling to provide informed consent
  • 5. Individuals unable/unwilling to undertake the protocol activities
  • 6. Individuals deemed appropriate for exclusion by their GP (e.g., on a palliative care register)
  • Matched controls - Group 1 (minimum of 500 participants):
  • 1. Individuals with a diagnosis of COVID-19 in CPRD Aurum or positive SARS CoV-2 RT-PCR result in SGSS or GP record
  • 2. Individuals coded in their primary care record as having suspected COVID-19
  • 3. Individuals aged under 18 years
  • 4. Individuals unable or unwilling to provide informed consent
  • 5. Individuals unable or unwilling to undertake the protocol activities
  • 6. Individuals deemed appropriate for exclusion by their GP (e.g., on a palliative care register)
  • Matched controls - Group 2 (50 participants):
  • 1. Participants unable/unwilling to provide informed consent
  • 2. Participants unable/unwilling to undertake the protocol activities
  • 3. Participants deemed appropriate for exclusion by their GP (e.g., on palliative care register)
  • Bio-sampling and wearables (BioWear) cohort (200 Long COVID participants, 50 participants from Control Group 1 and 50 participants from Control Group 2):
  • 1. Participants who have not previously consented to be contacted for bio-sampling/use of wearables
  • 2. Participants unable/unwilling to provide informed consent
  • 3. Participants unable/unwilling to undertake the protocol activities
  • Co-production workshops:
  • 1. Individuals unable/unwilling to provide informed consent
  • 2. Individuals unable/unwilling to attend a co-production workshop

研究者

相似试验